Potent oxazoline analogue of apratoxin C: synthesis, biological evaluation, and conformational analysis.
Potent oxazoline analogue of apratoxin C: synthesis, biological evaluation, and conformational analysis.
复制标题
apratoxin C 的有效恶唑啉类似物:合成、生物学评价和构象分析。
DOI:
10.1002/bip.22781
复制
发表时间:
2016
期刊:
影响因子:
--
通讯作者:
T.
中科院分区:
文献类型:
--
作者:
Yoshida;M.;Onda;Y.;Masuda;Y.;Doi;T.
In this research, the synthesis, biological evaluation, and conformational analysis of an apratoxin C oxazoline analog (3) have been demonstrated. The preparation of synthetic key intermediate9was achieved using an improved strategy that involves commercially available 3‐methylglutaric anhydride (12), an enzymatic enantioselective alcoholysis, and a diastereoselective reduction. The Pro‐Dtrina (3,7‐dihydroxy‐2,5,8‐trimethylnonanoic acid) moiety8was successfully synthesized in a similar manner as our previously reported synthesis of apratoxin C (1). The cyclization precursor5was formed after the coupling of Pro‐Dtrina8with a known tetrapeptide7to afford a linear peptide6, the formation of an oxazoline, and the removal of the protecting groups. Finally, the macrolactamization of5withO‐(7‐aza‐1H‐benzotriazol‐1‐yl)‐N,N,N′,N′‐tetramethyluronium hexafluorophosphate (HATU)/N,N‐diisopropylethylamine (DIEA) furnished an apratoxin C oxazoline analog (3), which exhibited a potent cytotoxicity against HeLa cells (IC50value of 22 nM) that was comparable with the cytotoxicity of apratoxin C (1) (IC50value of 4.2 nM). Conformational analyses of1and3through NMR experiments showed that oxazoline analog3formed a tertiary structure that was similar to the apratoxin C (1) structure in CD3CN, which provided a probable explanation for their comparable cytotoxicities. © 2015 Wiley Periodicals, Inc. Biopolymers (Pept Sci) 106: 404–414, 2016.